ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
3,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
4,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,2,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
5,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
5,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
6,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
8,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
8,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
9,1,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
10,1,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
11,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
11,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
12,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
13,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
13,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
14,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
14,2,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
14,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
14,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
14,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,Y
14,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
14,8,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
14,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
14,11,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,12,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
14,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,14,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,16,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
14,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
14,18,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
14,19,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Hilar lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
15,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
15,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
16,1,Forced vital capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
16,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
16,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
17,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
18,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
19,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
20,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
20,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
20,3,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
20,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
21,1,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
22,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
22,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
22,3,Pleurisy,Pleural infections and inflammations,Pleural disorders,Resp,N
22,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
23,1,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
23,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
23,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
23,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
24,1,Achromotrichia acquired,Pilar disorders NEC,Skin appendage conditions,Skin,N
24,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
24,3,Deafness,Hearing losses,Hearing disorders,Ear,N
24,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
24,5,Vogt-Koyanagi-Harada disease,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
25,1,Cataract nuclear,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
25,2,Choroidal neovascularisation,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
25,3,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
25,4,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
25,5,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
25,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
25,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
26,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
26,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
27,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
27,3,Hodgkin's disease,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
27,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
27,5,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
27,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
28,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
28,2,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
28,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
29,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
30,2,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
31,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
32,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
32,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
33,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
34,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
34,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
35,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
36,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
36,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
37,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
37,2,Pemphigus,Bullous conditions,Epidermal and dermal conditions,Skin,N
37,3,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
38,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
38,2,Fulminant type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
40,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
40,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
41,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
41,2,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
42,1,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
42,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
43,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
44,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
44,2,Diarrhoea infectious,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
44,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
44,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
44,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
44,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
45,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
46,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
46,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
47,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
48,1,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
49,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
49,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
49,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
49,4,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
49,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
49,6,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
50,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
50,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
50,3,Oncologic complication,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
51,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
51,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
51,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
52,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
52,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,Y
53,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
54,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
54,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
54,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
54,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,5,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
54,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
56,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
57,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
58,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
58,2,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
59,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
59,2,Craniofacial fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
59,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
59,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
59,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
60,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
61,1,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
61,2,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
61,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
62,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
63,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
63,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
64,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
64,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
65,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
66,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
66,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
67,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
68,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
69,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
70,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
71,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
72,1,Cutaneous sarcoidosis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
72,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
72,3,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
73,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
73,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
73,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,4,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
73,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
73,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
74,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
74,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
75,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
76,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,Y
76,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
77,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
78,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
78,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
78,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,2,Gingival disorder,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
79,3,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
80,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
80,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
80,3,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
81,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
81,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
81,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
81,5,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
82,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
82,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
82,3,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
83,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
83,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
84,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
85,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
85,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
85,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
85,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
87,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
88,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
88,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
89,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
89,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
89,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
90,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
90,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
90,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
90,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
90,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
90,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
91,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
92,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
92,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
92,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
92,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
92,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
92,7,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
92,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
93,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
93,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
93,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
93,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
93,5,Oesophageal neoplasm,Oesophageal neoplasms malignancy unspecified,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
94,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
95,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
95,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
96,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
97,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
97,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
97,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
97,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
97,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,Y
97,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
98,1,Ketosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
98,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
99,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
99,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
99,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
99,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
99,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
100,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
101,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
102,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
103,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
104,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
105,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
105,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
105,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
106,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,3,Metastases to spleen,Metastases to specified sites,Metastases,Neopl,N
106,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
106,5,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,Y
106,6,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
107,1,Lung adenocarcinoma recurrent,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
108,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
110,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
111,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
111,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
112,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
112,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
112,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
113,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
113,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
114,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
114,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
114,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
114,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
116,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
116,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
116,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
116,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
116,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
117,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
117,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
117,3,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
118,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
119,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
120,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
121,1,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
122,1,Chronic cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
123,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
123,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
123,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
124,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
125,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
125,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
125,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
125,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
125,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
125,7,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
126,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
127,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
127,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
127,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
128,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
128,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
129,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
130,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
130,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,4,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
130,5,Pulmonary artery occlusion,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
130,6,Superior vena cava syndrome,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
131,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
132,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
133,1,Scleroderma-like reaction,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
134,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
134,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,3,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
135,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
135,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
135,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
136,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
137,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
138,1,Cancer surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
139,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
140,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
140,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
140,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
140,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
141,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
141,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
141,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
141,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
142,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
142,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
142,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
143,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
144,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
145,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
146,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
147,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
147,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
147,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
148,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
148,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
149,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
149,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
150,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
150,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
150,3,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
151,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
151,2,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
152,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
152,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
152,3,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
153,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
153,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,Y
153,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
153,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
153,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
154,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
155,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
156,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
156,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
156,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
156,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
156,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
156,6,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
157,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
158,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
158,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
158,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
159,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
159,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
160,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
160,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
160,4,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
161,2,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
162,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
162,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
163,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
163,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
163,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
164,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
164,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
164,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
164,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
164,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
164,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
164,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
164,8,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
164,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
165,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
165,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
165,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
166,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
167,1,Macular degeneration,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
168,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
169,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
169,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
170,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
171,1,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
171,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
171,3,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
172,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
172,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
172,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
172,4,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,Y
173,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
173,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
173,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
174,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
175,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
175,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
175,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
175,4,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
175,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
176,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
176,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
176,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
176,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
176,6,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
176,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
177,1,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
178,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
178,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
178,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
180,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
180,2,Headache,Headaches NEC,Headaches,Nerv,N
180,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
182,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
183,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
183,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
184,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
185,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
186,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
187,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
187,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
188,1,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
189,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
189,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
190,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
191,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
192,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
193,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
193,2,Neurodegenerative disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
194,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
194,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
194,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
194,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
194,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
195,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
195,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
195,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
195,4,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,5,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
195,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
196,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
197,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
197,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
198,1,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
199,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
200,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
200,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
201,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
201,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
202,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
202,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
202,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
203,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
204,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
204,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
205,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
205,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
206,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
206,2,Deafness,Hearing losses,Hearing disorders,Ear,N
206,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
207,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
209,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
209,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
210,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
211,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
211,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
212,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
212,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
212,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
213,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
214,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
214,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
214,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
214,4,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
215,1,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
215,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
215,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
216,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
217,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
217,2,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
217,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
217,4,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
218,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
218,2,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
218,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
219,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
219,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
219,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
219,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
219,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
220,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
220,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
221,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
222,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
223,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
224,1,Pre-existing condition improved,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
224,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
226,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
226,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
227,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
227,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
227,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
228,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
228,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
229,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
229,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
230,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
231,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
231,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
232,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
232,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
233,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
233,2,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
233,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
234,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
235,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
235,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
236,1,Autoimmune hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
236,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
237,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
237,2,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
237,3,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
237,4,Scleroderma-like reaction,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
237,5,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
238,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
238,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
238,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
238,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
239,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
239,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
240,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
240,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
240,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
240,4,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
240,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
241,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
241,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
243,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
244,1,Hyperpituitarism,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
245,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
245,2,Autoimmune myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
245,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
245,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
245,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
246,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
247,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
247,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
247,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
247,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
247,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
247,7,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
247,8,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
248,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
249,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
249,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
250,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
250,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
250,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
250,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
251,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
251,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
251,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
251,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
251,5,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
251,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
251,7,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
252,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
252,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
253,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
253,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
253,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
253,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
254,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
255,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
255,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
255,3,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
255,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
255,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
255,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
255,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
256,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
256,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
256,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
257,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,Y
258,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
258,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
258,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
258,4,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
259,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
259,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
260,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
260,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
261,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
262,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
262,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
262,4,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
262,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
262,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
262,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
262,8,Tumour pain,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
263,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
264,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
265,1,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
266,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
266,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
266,3,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
266,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
267,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
267,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
268,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
268,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
269,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
270,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
270,2,Headache,Headaches NEC,Headaches,Nerv,N
270,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
270,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
271,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
271,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
272,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
272,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
273,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
273,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
273,3,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
273,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
273,5,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
274,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
274,2,Thyroxine free increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
274,3,Tri-iodothyronine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
275,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
276,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
277,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
277,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
278,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
278,2,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
278,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
278,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
279,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
279,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
279,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
280,1,Autoimmune arthritis,Arthropathies NEC,Joint disorders,Musc,N
281,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
282,1,Chvostek's sign,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
282,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
282,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
283,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
283,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
283,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
284,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
284,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
285,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
285,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,3,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
285,4,Mucous stools,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
285,5,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
286,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
287,1,Atrial tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
287,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
288,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
288,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
288,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
289,1,Acquired tracheo-oesophageal fistula,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
289,2,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
290,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
290,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
290,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
290,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
291,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
291,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
291,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
292,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
292,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
292,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
292,4,Body temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
292,5,Endocrine toxicity,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
292,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
292,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
292,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
292,9,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
292,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
292,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
293,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
293,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
293,3,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
293,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
294,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
294,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
295,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
295,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
295,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
296,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
297,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
298,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
299,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
299,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
299,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
300,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
300,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
301,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
301,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
301,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
302,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
303,1,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
303,2,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
303,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
303,4,Vanishing bile duct syndrome,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
304,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
304,2,Entropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
304,3,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
305,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
306,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,Y
306,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
306,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
306,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
306,5,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
306,6,Nephritis,Nephritis NEC,Nephropathies,Renal,N
307,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
307,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
308,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
308,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
308,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
309,1,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
309,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
310,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
311,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
312,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
312,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
313,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
313,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
313,3,Pruritus allergic,Pruritus NEC,Epidermal and dermal conditions,Skin,N
314,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
314,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
315,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
315,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
316,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
317,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
317,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
318,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
318,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
319,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
319,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
320,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
320,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
321,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
321,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
321,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
321,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
321,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
322,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
322,2,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
322,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
323,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
323,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
323,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
323,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
323,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
323,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
323,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
324,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
324,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
324,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
324,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
324,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
324,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
325,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
326,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
326,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
327,1,Adrenocorticotropic hormone deficiency,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
327,2,Autoimmune hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
327,3,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
327,4,Lymphocytic hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
327,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
328,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
328,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
328,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
328,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
328,5,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
328,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
328,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
328,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
328,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
329,1,Hanging,Death and sudden death,Fatal outcomes,Genrl,Y
330,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
330,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
331,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
332,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
332,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
332,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
333,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
333,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
333,3,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
334,1,Subacute cutaneous lupus erythematosus,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
335,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
336,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
337,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
337,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
338,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
338,2,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,Y
339,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
340,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
341,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
342,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
342,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
342,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
342,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
342,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
342,6,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
342,7,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
343,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
343,2,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
343,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
344,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
345,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
345,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
346,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
347,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
347,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
348,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
349,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
349,2,Epiglottic erythema,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
349,3,Epiglottic oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
349,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
350,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
351,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
351,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
353,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
354,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
354,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
355,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
355,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
355,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
355,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
355,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
356,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
356,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
357,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
357,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
358,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
358,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
358,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
358,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
359,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
359,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
360,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
360,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
360,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
360,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
360,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
360,6,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
360,7,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
361,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
361,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
362,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
363,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
363,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
363,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
364,2,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
364,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
364,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
364,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
365,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
366,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
366,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
366,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
367,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
368,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
368,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
369,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
369,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
370,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
370,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
370,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
370,4,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
370,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
370,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
370,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
370,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
370,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
370,10,Suprapubic pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
371,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
371,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
372,1,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
373,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
375,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
375,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
375,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
375,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
376,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
376,2,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
376,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
376,4,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
377,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
378,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
378,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
379,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
379,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
380,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
380,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
380,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
380,4,Nephritis,Nephritis NEC,Nephropathies,Renal,N
381,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
382,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
382,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
382,4,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
383,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
383,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
384,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
384,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
385,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
386,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
387,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
387,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
388,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
389,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
389,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
389,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
390,1,Encephalitis autoimmune,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,Y
390,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
391,1,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
392,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
392,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
392,3,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
392,4,Cholangiolitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
392,5,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
392,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
392,7,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
392,8,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
392,9,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
392,10,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
392,11,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
392,12,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
392,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
392,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
392,15,Red blood cell agglutination,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
393,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
393,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
394,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
394,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
394,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
394,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
395,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
395,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
395,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
396,1,Vogt-Koyanagi-Harada disease,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
397,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
397,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
397,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
397,4,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
398,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
398,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
399,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
399,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
399,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
399,4,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
400,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
401,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
401,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
401,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
401,4,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
401,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
402,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
402,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
403,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
403,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
404,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
404,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
405,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
405,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
405,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
406,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
407,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
408,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
409,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
409,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
409,6,PCO2 increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
410,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
410,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
410,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
410,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
410,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
410,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
411,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
412,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
414,1,Immune-mediated endocrinopathy,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
415,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
415,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
416,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
417,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
417,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
418,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
418,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
418,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
418,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
418,5,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
418,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
418,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
418,8,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
418,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
418,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
419,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
420,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
421,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
421,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
422,1,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
422,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
423,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
424,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
424,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
425,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
425,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
426,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
427,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
428,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
428,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
428,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
428,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
429,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
430,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
431,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
432,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
432,2,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
432,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
433,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
434,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
435,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
435,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
436,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
437,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
437,2,Cerebellar syndrome,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
437,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
437,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
437,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
437,6,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
437,7,Headache,Headaches NEC,Headaches,Nerv,N
437,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
438,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
438,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
439,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
439,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
439,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
439,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
439,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
441,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
441,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
442,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
442,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
442,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
443,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
443,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
443,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
444,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
445,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
445,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
445,3,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
446,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
447,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
447,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
447,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
448,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
448,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
449,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
450,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
450,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
451,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
451,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
451,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
452,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
452,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
452,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
452,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
453,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
453,2,Headache,Headaches NEC,Headaches,Nerv,N
454,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
454,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
455,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
455,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
456,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
456,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
457,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
458,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
458,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
458,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
459,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
460,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
461,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
461,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
461,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
461,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
462,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
463,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
463,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
463,3,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
464,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
465,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
466,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
466,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
466,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
467,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
468,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
468,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
469,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
469,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
470,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
470,2,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
470,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
470,4,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
470,5,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
471,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
472,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
472,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
473,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
474,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
475,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
475,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
476,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
477,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
477,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
477,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
477,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
477,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
478,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
479,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
480,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
480,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
480,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
480,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
480,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
480,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
481,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
481,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
481,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
482,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
482,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
483,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
483,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
483,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
484,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
484,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
484,3,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
484,4,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
485,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
485,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
485,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
486,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
486,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
486,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
487,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
488,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
488,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
488,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
489,1,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
489,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
489,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
489,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
489,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
489,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
491,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
491,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
491,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
491,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
492,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
492,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
492,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
492,4,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
492,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
493,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
493,2,Immune-mediated hepatic disorder,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
494,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
495,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
495,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
496,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
497,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
497,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
497,3,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
497,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
497,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
497,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,1,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
498,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
498,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
498,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
498,5,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
499,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
499,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
500,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
500,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
500,3,Headache,Headaches NEC,Headaches,Nerv,N
501,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
501,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
501,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
501,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
501,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
501,6,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
501,7,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
501,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
502,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
503,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
504,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
504,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
505,1,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
506,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
508,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
509,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
510,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
511,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
511,2,Corneal graft rejection,Transplant rejections,Immune disorders NEC,Immun,N
512,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
512,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
513,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
513,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
514,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
515,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
516,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
516,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
516,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
516,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
517,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
517,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
518,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
518,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
519,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
519,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
519,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
519,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
520,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
521,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
521,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
521,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
521,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
522,1,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
523,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
523,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
524,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
524,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
524,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
525,1,Choroidal detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
525,2,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
525,3,Posterior capsule opacification,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
525,4,Serous retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
525,5,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
526,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
527,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
528,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
528,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
528,4,Sarcopenia,Muscle weakness conditions,Muscle disorders,Musc,N
529,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
530,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
530,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
531,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
531,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
531,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
532,1,Headache,Headaches NEC,Headaches,Nerv,N
532,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
532,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
533,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
533,2,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
533,3,Squamous cell carcinoma of the vulva,Vulval neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
534,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
535,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
536,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
536,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
536,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
536,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
536,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
537,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
537,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
537,3,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
538,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
538,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
538,3,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
538,4,Lacunar stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
538,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
539,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
539,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
540,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
540,3,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
540,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
540,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
540,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
540,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
540,8,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
541,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
541,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
541,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
542,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
542,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
542,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
543,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
543,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
544,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
545,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
546,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
546,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
547,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
548,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
549,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
549,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
549,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
550,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
550,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
550,3,Myopathy,Myopathies,Muscle disorders,Musc,N
550,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
550,5,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,Y
550,6,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
551,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
552,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
553,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
553,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
553,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
553,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
553,6,Headache,Headaches NEC,Headaches,Nerv,N
553,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
553,9,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
553,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
554,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
554,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
554,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
555,1,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
556,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
556,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
557,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
557,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
559,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
559,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
560,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
561,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
561,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
562,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
562,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
562,3,Autoimmune nephritis,Nephritis NEC,Nephropathies,Renal,Y
562,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
563,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
563,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
563,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
563,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
564,1,Corneal degeneration,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
565,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
565,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
565,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
565,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
565,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
565,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
565,7,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
565,8,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
565,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
565,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
565,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
566,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
566,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
566,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
566,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
566,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
567,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
567,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
567,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
568,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
569,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
570,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
570,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
571,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
572,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
572,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
573,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
573,2,Malignant pleural effusion,Pleural neoplasms,Pleural disorders,Resp,N
574,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
574,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
574,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
574,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
574,6,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
575,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
575,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
576,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
576,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
576,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
576,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
577,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
578,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
578,2,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
578,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
578,4,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
579,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
580,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
580,2,IgA nephropathy,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
580,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
581,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
581,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
581,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
582,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
583,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
583,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
584,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
584,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
585,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
585,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
585,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
586,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
587,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
587,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
589,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
589,2,Tongue discolouration,Tongue signs and symptoms,Tongue conditions,Gastr,N
590,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
590,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
591,1,Bladder cancer recurrent,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
592,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
593,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
594,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
594,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
595,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
595,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
596,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
597,1,Lichenoid keratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
597,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
598,1,Chronic actinic dermatitis,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
599,1,Lichen planopilaris,Alopecias,Skin appendage conditions,Skin,N
600,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
600,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
600,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
601,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
602,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
603,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
604,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
605,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
605,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
606,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
606,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
606,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
606,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
606,5,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
607,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
608,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
608,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
608,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
608,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
608,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
608,6,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
608,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
609,1,Bladder cancer recurrent,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
609,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
610,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
611,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
611,2,Axonal neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
611,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
611,4,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
611,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
611,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
611,7,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
612,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
612,2,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
612,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
612,4,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
613,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
613,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
613,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
613,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
613,5,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
614,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
614,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
614,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
615,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
615,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
615,3,Mucocutaneous ulceration,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
615,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
615,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
615,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
615,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
615,8,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
616,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
616,2,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
616,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
617,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
618,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
618,2,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
618,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
619,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
620,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
620,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
621,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
622,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
622,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
622,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
622,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
622,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
622,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
622,8,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
623,1,Immune-mediated gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
624,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
624,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
624,3,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
624,4,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
624,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
624,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
624,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
624,8,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,Y
624,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
624,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
625,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
626,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
626,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
626,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
627,1,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
627,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
627,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
628,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
628,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
630,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
631,1,Nasopharyngeal cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
632,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
632,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
632,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
632,4,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
632,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
633,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
634,1,Paranasal sinus and nasal cavity malignant neoplasm,Paranasal sinus and nasal cavity neoplasms malignant and unspecified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
635,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
636,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
637,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
637,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
637,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
638,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
638,2,Alopecia scarring,Alopecias,Skin appendage conditions,Skin,N
638,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
638,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
638,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
638,6,Lichen planopilaris,Alopecias,Skin appendage conditions,Skin,N
638,7,Madarosis,Alopecias,Skin appendage conditions,Skin,N
638,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
638,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
639,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
640,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
640,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
642,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
642,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
643,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
644,1,Immune-mediated adverse reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
644,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
644,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
644,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,1,Lichen planopilaris,Alopecias,Skin appendage conditions,Skin,N
646,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
646,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
647,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
647,2,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
648,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
648,2,Vocal cord disorder,Laryngeal and adjacent sites disorders NEC (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
649,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
650,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
651,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
651,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
652,1,Cataract nuclear,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
652,2,Chorioretinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
652,3,Choroidal detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
652,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
652,5,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
652,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
652,7,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
652,8,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
652,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
653,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
654,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
654,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
654,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
654,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
654,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
654,6,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
654,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
654,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
655,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
656,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
657,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
657,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
658,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
659,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
660,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
660,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
661,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
662,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
662,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
663,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
664,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
665,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
666,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
667,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,Y
668,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
668,2,Cortisol increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
668,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
668,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
668,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
668,6,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
668,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
668,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
668,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
668,10,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
668,11,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
669,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
669,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
669,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
669,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
670,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
670,2,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,Y
670,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
670,4,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
670,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
670,6,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
670,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
671,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
672,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
672,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
672,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
673,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
673,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
674,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
675,1,Autoimmune myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
676,1,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
677,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
678,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
678,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
679,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
679,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
680,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
681,1,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
681,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
681,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
681,4,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
681,5,Hypothalamo-pituitary disorder,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
681,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
681,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
681,8,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
682,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
683,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
684,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
684,2,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
685,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
686,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
687,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
688,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
688,2,Foetal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
688,3,Neonatal respiratory depression,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
689,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
689,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
690,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
691,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
693,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
694,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
695,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
696,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
696,3,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
696,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
696,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
696,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
696,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
696,8,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
696,9,Procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
696,10,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
696,11,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
696,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
697,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
697,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
698,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
699,1,Hidradenitis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
700,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
701,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
702,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
702,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
702,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
703,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
703,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
703,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
704,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
704,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
704,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
704,4,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
704,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
704,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
705,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
705,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
706,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
707,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
707,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
707,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
707,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
708,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
708,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
708,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
708,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
708,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
709,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
710,1,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
711,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
711,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
711,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
711,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
711,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
711,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
711,7,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
711,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
711,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
711,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
712,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
712,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
712,3,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
712,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
712,5,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
712,6,Myasthenic syndrome,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
712,7,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
712,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
712,9,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
713,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
713,2,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
713,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
713,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
713,5,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
713,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
713,7,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
713,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
713,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
713,10,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
713,11,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
714,1,Diffuse uveal melanocytic proliferation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
714,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,1,Diffuse uveal melanocytic proliferation,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
715,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
716,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
716,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
716,3,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
717,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
718,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
718,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
718,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
718,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
718,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
718,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
718,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
718,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
719,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
720,1,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
720,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
721,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
721,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
721,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
722,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
722,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
723,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
724,1,Blepharospasm,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
724,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
724,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
724,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
724,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
724,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
724,7,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
724,8,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
724,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
724,10,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
724,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
725,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
725,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
725,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
725,4,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
725,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
725,6,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
726,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
727,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
727,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
727,3,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
728,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
728,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
728,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
728,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
728,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
728,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
729,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
729,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
729,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
729,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
730,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
730,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
730,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
730,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,Y
730,6,Phrenic nerve paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
731,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
732,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
732,2,Dry gangrene,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
732,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
733,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
734,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
735,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
735,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
735,3,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
735,4,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
736,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
737,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
737,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
737,3,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
737,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
737,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
737,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
737,7,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
737,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
737,9,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
737,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
737,11,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
737,12,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
737,13,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
737,14,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
737,15,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
737,16,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
737,17,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
737,18,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
737,19,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
737,20,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
737,21,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
737,22,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
738,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
739,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
740,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
740,2,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
740,3,C-reactive protein abnormal,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
740,4,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
740,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
740,6,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
740,7,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
740,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
740,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
740,10,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
740,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
741,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
742,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
742,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
743,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
744,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
745,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
745,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
745,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
745,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
745,5,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
745,6,Respiratory tract inflammation,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
745,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
746,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
746,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
746,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
746,4,Malignant dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
746,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
746,6,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
746,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
747,1,Acute interstitial pneumonitis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
748,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
748,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
749,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
750,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
750,2,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
750,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
750,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
750,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
750,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
750,7,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
750,8,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
750,9,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
750,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
751,1,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
751,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
751,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
751,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
751,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
751,6,Necrotising myositis,Myopathies,Muscle disorders,Musc,N
751,7,Overlap syndrome,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
752,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
752,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
752,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
752,4,Necrotising myositis,Myopathies,Muscle disorders,Musc,N
753,1,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
753,2,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
753,3,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
753,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
754,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
755,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
756,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
756,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
757,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
757,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
758,1,Acne,Acnes,Skin appendage conditions,Skin,N
758,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
758,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
758,4,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
758,5,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
758,6,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
758,7,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
758,8,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
758,9,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
758,10,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
758,11,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
758,12,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
758,13,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
758,14,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
758,15,Ephelides,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
758,16,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
758,17,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
758,18,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
758,19,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
758,20,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
758,21,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
758,22,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
758,23,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
758,24,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
758,25,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
758,26,Myalgia,Muscle pains,Muscle disorders,Musc,N
758,27,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
758,28,Nail pitting,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
758,29,Nail ridging,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
758,30,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
758,31,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
758,32,Oral hyperaesthesia,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
758,33,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
758,34,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
758,35,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
758,36,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
758,37,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
758,38,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
758,39,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
758,40,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
758,41,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
758,42,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
758,43,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
758,44,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
758,45,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
758,46,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
758,47,Urethral operation,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
758,48,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
758,49,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
759,1,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
759,2,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
760,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
761,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
761,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
761,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
762,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
763,1,Immune-mediated neurological disorder,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
764,1,Immune-mediated neurological disorder,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
764,2,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
765,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
765,2,Immune-mediated neurological disorder,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
765,3,Immune-mediated neurological disorder,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
765,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
766,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
766,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
766,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
766,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
766,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
766,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
767,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
768,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
768,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
768,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
769,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
769,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,3,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
770,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
770,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
770,3,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
770,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
771,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
771,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
772,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
772,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
773,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
773,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
773,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
773,4,Antiphospholipid antibodies positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
773,5,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,6,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
773,7,Arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
773,8,Blood creatine phosphokinase abnormal,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
773,9,Blood pressure difference of extremities,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
773,10,Brain natriuretic peptide abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
773,11,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
773,12,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
773,13,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
773,14,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
773,15,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
773,16,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,17,Eosinophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
773,18,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
773,19,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
773,20,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
773,21,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
773,22,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
773,23,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
773,24,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
773,25,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
773,26,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
773,27,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
773,28,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
773,29,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
773,30,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
773,31,Paraneoplastic syndrome,Paraneoplastic syndromes NEC,Neoplasm related morbidities,Neopl,N
773,32,Physical deconditioning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
773,33,Polyarteritis nodosa,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
773,34,Positron emission tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
773,35,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
773,36,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
773,37,Renal vessel disorder,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
773,38,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,39,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
773,40,Troponin abnormal,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
773,41,Vasculitis gastrointestinal,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
773,42,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,43,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,44,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
774,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
774,2,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
774,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
774,4,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
775,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
775,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
775,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
775,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
775,5,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
775,6,Hypovitaminosis,Vitamin deficiencies NEC,Vitamin related disorders,Metab,N
775,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
775,8,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
775,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
775,10,Pancreatic failure,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
775,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
776,1,Colon cancer metastatic,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
776,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
776,3,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
776,4,Metastases to kidney,Metastases to specified sites,Metastases,Neopl,N
776,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
777,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
778,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
778,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
778,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
778,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
779,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
779,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
779,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
780,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
780,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
780,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
780,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
781,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
782,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
783,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
783,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
783,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
783,4,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
784,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
784,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
785,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
785,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
785,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
785,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
786,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
787,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
787,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
788,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
788,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
788,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
788,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
788,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,6,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
789,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
790,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
790,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
790,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
790,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
791,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
792,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
792,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
793,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
794,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
794,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
794,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
794,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
795,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
795,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
795,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
795,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
795,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
797,1,Myasthenia gravis crisis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
798,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
799,1,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
799,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
799,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
799,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
800,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
801,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
801,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
801,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
801,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
802,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
803,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
804,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
804,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
805,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
806,1,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
806,2,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
806,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
806,4,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
807,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
808,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
808,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
808,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
808,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
808,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
808,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
809,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
809,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
810,1,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
811,1,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
811,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
811,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
811,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
811,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
811,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
812,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
812,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
813,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
814,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
814,2,Bedridden,Disability issues,Lifestyle issues,SocCi,N
814,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
814,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
814,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
814,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
814,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
815,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
815,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
815,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
816,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
816,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
816,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
816,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
817,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
817,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
818,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
819,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
820,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
821,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
821,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
821,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
821,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
821,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,6,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
821,7,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
821,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
822,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
823,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
823,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
824,1,Bladder cancer recurrent,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
825,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
825,2,Positron emission tomogram abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
825,3,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
825,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
826,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
826,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
826,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
827,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
829,1,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
830,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
831,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
832,1,Hepatitis B reactivation,Hepatitis virus infections,Viral infectious disorders,Infec,N
833,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
833,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
834,1,Cogan's syndrome,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,Y
834,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
834,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
834,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
834,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
834,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
834,7,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
834,8,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
834,9,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
834,10,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
834,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
835,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
836,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
837,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
837,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
837,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
838,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
838,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
839,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
840,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
841,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
842,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
842,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
843,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
844,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
844,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
845,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
846,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
847,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
848,1,Colorectal cancer recurrent,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
848,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
849,1,Biliary tract disorder,Structural and other bile duct disorders,Bile duct disorders,Hepat,N
850,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
850,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
850,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
850,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
850,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
851,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
852,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
853,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
854,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
854,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
854,3,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
854,4,Device ineffective,Device issues NEC,Device issues,Prod,N
854,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
854,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
854,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
854,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
854,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
854,10,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
854,11,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
854,12,Tracheal mass,Tracheal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
855,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
855,2,Hepatitis chronic persistent,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
855,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
855,4,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
855,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
856,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
856,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
856,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
856,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
856,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
856,6,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
856,7,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
856,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
856,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
856,10,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
857,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
857,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
857,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
857,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
857,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
857,6,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
857,7,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
857,8,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
857,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
857,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
858,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
858,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
859,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
859,2,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
859,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
859,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
859,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
859,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
859,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
859,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
859,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
859,10,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
859,11,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
859,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
859,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
859,14,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
859,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
859,16,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
859,17,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
859,18,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
859,19,Headache,Headaches NEC,Headaches,Nerv,N
859,20,Headache,Headaches NEC,Headaches,Nerv,N
859,21,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
859,22,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
859,23,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
859,24,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
859,25,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
859,26,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
859,27,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
859,28,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
859,29,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
860,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
861,1,Acquired haemophilia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
862,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
862,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
862,3,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
863,1,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
863,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
863,3,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
864,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
865,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
866,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
866,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
866,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
866,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
867,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
867,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
868,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
869,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
869,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
870,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
871,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
872,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
872,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
873,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
874,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
874,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
875,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
875,2,Cardiac dysfunction,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
875,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
875,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
876,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
876,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
876,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
876,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
877,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
877,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
878,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
879,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
879,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
880,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
880,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
881,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
882,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
882,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
882,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
882,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
883,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
883,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
884,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
884,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
885,1,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
885,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
885,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
886,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
887,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
887,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
887,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
887,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
887,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
887,6,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
887,7,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
887,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
887,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
887,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
887,11,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
887,12,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
887,13,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
887,14,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
887,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
887,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
887,17,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
887,18,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
887,19,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
887,20,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
887,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
888,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
889,3,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
889,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
889,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
889,6,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
889,7,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
889,8,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
889,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
889,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
889,11,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
889,12,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
889,13,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
889,14,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
889,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
889,16,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
889,17,Oedema mucosal,Mucosal findings abnormal,General system disorders NEC,Genrl,N
889,18,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
889,19,Pulse abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
889,20,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
889,21,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
890,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
890,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
890,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
891,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
892,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
893,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
894,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
895,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
895,2,Gene mutation identification test positive,Gene analyses,Cytogenetic investigations and genetic analyses,Inv,N
896,1,Brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
896,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
897,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
898,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
898,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
898,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
899,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
900,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
900,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
902,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
902,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
902,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
902,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
903,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
903,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
903,3,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
903,4,Lichen planus pemphigoides,Bullous conditions,Epidermal and dermal conditions,Skin,N
903,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
903,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
903,7,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
903,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
903,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
904,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
904,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
905,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
905,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
906,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
906,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
907,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
907,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
908,1,Neuropsychological symptoms,Mental disorders due to a general medical condition NEC,Psychiatric disorders NEC,Psych,N
909,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
910,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
911,1,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
912,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
913,1,Immune-mediated nephritis,Nephritis NEC,Nephropathies,Renal,N
914,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
915,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
915,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
915,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
916,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
917,1,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
918,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
919,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
920,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
920,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
920,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
921,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
921,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
921,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
922,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
922,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
922,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
922,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
922,5,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
923,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
923,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
924,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
925,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
925,2,Thyroid hormones decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
925,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
926,1,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
926,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
927,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
928,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
929,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
930,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
930,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
930,3,Protein urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
931,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
932,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
932,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
932,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
933,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
934,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
935,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
935,2,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
936,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
936,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
936,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
937,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
938,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
938,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
939,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
939,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
939,3,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
940,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
940,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
941,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
942,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
942,2,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
942,3,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
943,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
944,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
944,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
944,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
944,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
944,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
944,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
945,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
946,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
947,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
947,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
948,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
949,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
950,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
951,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
951,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
951,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
952,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
953,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
953,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
954,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
954,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
954,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
954,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
955,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
955,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
955,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
955,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
956,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
957,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
957,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
957,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
958,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
959,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
960,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
961,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
962,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
962,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
962,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
962,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
963,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
964,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
965,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
966,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
966,2,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
967,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
968,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
969,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
970,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
970,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
971,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
972,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
972,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
973,1,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
973,2,Immune-mediated uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
974,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
975,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
975,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
975,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
975,4,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
976,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
976,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
976,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
976,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
977,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
977,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
977,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
978,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
979,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
980,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
980,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
981,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
981,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
982,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
982,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
982,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
982,4,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
982,5,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
982,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
982,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
982,8,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
982,9,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
982,10,Lung squamous cell carcinoma stage III,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
982,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
982,12,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
982,13,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
982,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
982,15,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
982,16,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
982,17,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
983,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
983,2,Emphysema,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
983,4,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,5,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
983,6,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
984,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
984,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
985,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
986,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
986,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
986,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
986,4,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
986,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
986,6,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
986,7,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
987,1,Erythema induratum,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
987,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
987,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
987,4,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
988,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
988,2,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
988,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
988,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
988,5,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
988,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
989,1,Erythrodermic psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
989,2,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
989,3,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
990,1,Eosinophilic fasciitis,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
990,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
991,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
992,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
993,1,Immune-mediated lung disease,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
994,1,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
995,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
995,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
996,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
997,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
997,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
998,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
998,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
999,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1000,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1000,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1001,1,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
1001,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
1002,1,Immune-mediated dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1002,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1002,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1002,4,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1003,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1004,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1004,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1004,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1004,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1004,5,Peptic ulcer,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1004,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1004,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1005,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1005,2,Giant cell arteritis,Arterial infections and inflammations,Vascular infections and inflammations,Vasc,N
1006,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1006,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1006,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1006,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1006,5,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1006,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1006,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1006,8,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1007,1,Immune-mediated thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1007,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1007,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1008,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1009,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1009,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1009,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1009,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1010,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1010,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1010,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1010,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1010,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1010,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1010,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1010,8,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1010,9,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1010,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1010,11,Radiation injury,Radiation injuries,Injuries by physical agents,Inj&P,N
1010,12,Radiotherapy to brain,Brain radiotherapies,"Nervous system, skull and spine therapeutic procedures",Surg,N
1010,13,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1010,14,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1011,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1011,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1011,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1011,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1011,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1011,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1011,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1012,1,Blood thyroid stimulating hormone abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1012,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1012,3,Thyroxine abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1013,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1013,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1014,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1015,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1016,1,Headache,Headaches NEC,Headaches,Nerv,N
1016,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1017,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1018,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1019,1,Blood thyroid stimulating hormone abnormal,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1019,2,Thyroxine abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1020,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1020,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1020,3,Thyroxine abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1021,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1022,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1022,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1022,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1023,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1024,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1025,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1026,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1027,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1028,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1029,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1030,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1030,2,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1030,3,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1031,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1031,2,Sarcomatoid carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1032,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1033,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1034,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1035,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1036,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1036,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1036,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1036,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1037,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1038,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1038,2,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1038,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1038,4,Ocular myasthenia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1038,5,Tissue infiltration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1039,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1040,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1041,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1041,2,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1042,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1043,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
1043,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1044,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1045,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1046,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1046,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1046,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1046,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1047,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1048,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1049,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1050,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1050,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1051,1,Cystitis noninfective,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
1051,2,Urethritis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1052,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1052,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1052,3,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1052,4,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,Y
1053,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1054,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1054,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1054,3,Pemphigoid,Bullous conditions,Epidermal and dermal conditions,Skin,N
1054,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1055,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1055,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1055,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1056,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1056,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1057,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1058,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1059,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1060,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1061,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1062,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1062,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1062,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1063,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1063,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1064,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1064,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1065,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1066,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1066,2,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1066,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1066,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1066,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1067,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1067,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1067,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1067,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1067,5,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1067,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1068,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1069,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1069,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1069,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1069,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1069,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1069,6,Palatal swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1069,7,Rhinalgia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1069,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1070,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1071,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1072,1,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1072,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1073,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1073,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1073,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1073,4,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1073,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1073,6,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1073,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1073,8,Headache,Headaches NEC,Headaches,Nerv,N
1073,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1073,10,Lymph nodes scan abnormal,Bone marrow and immune tissue imaging procedures,Haematology investigations (incl blood groups),Inv,N
1073,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1073,12,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1073,13,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1074,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1075,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1076,1,Catheter site rash,Implant and catheter site reactions,Administration site reactions,Genrl,N
1077,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1077,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1077,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1077,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1078,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1079,1,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1080,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1081,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1082,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1082,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1082,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1082,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1083,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1083,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1083,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1084,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1084,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1084,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1085,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1086,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1087,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1087,2,Carotid artery stenosis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1087,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1087,4,Essential thrombocythaemia,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1087,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1087,6,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1087,7,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1087,8,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1087,9,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1087,10,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
1088,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
1089,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1090,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1090,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1091,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1091,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1092,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1093,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1093,2,Enterostomy,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1093,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1093,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1093,5,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1094,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1095,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1095,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1096,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1096,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1097,1,Hypophysitis,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1098,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1098,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1099,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1100,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1101,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1101,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1102,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1103,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1104,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1104,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1105,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1105,2,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1105,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1105,4,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1105,5,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1105,6,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1106,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1106,2,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1106,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
1107,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1107,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1108,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1108,2,Gastrointestinal fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1108,3,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
1109,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1109,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1109,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1109,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1109,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1110,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1111,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1111,2,Thyroid function test abnormal,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1112,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1112,2,Immune-mediated arthritis,Arthropathies NEC,Joint disorders,Musc,N
1112,3,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1112,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1113,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1113,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1113,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1113,4,Atrioventricular block second degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1113,5,Blood bilirubin abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1113,6,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1113,7,Blood phosphorus abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1113,8,Blood potassium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1113,9,Brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1113,10,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1113,11,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1113,12,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1113,13,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1113,14,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1113,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1113,16,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1113,17,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1113,18,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1113,19,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1113,20,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
1113,21,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1113,22,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1113,23,Jejunal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1113,24,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1113,25,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1113,26,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1113,27,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1113,28,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1113,29,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1113,30,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1113,31,Thyroxine increased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1113,32,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1113,33,Ventricular hypokinesia,Myocardial disorders NEC,Myocardial disorders,Card,N
1113,34,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1114,1,Cerebral artery thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1114,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1114,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1114,4,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1114,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1114,6,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1114,7,Thrombotic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1115,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1115,2,Tongue cancer recurrent,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1116,1,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1116,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1116,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1117,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1117,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1118,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1118,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1120,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1120,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1121,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1121,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1121,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1121,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1122,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1122,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1123,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1124,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1125,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1125,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1125,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1125,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1125,5,Vascular access complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1126,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1126,2,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1126,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1126,4,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1126,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1126,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1127,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1129,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1130,1,Blood thyroid stimulating hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1130,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1131,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1132,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1133,1,Insurance issue,Economic circumstances,Economic and housing issues,SocCi,N
1133,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1133,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1133,4,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1134,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1134,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1135,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1135,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1135,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1135,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1135,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1135,6,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1136,1,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1137,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1137,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1138,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1138,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1139,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1140,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1140,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1140,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1141,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1142,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1142,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1142,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1142,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1143,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1143,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1143,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1144,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1144,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1144,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1144,4,Stress fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1144,5,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1145,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1146,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1146,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1146,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1147,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1148,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1148,2,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
1148,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1148,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1148,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1148,6,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1149,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1150,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1151,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1151,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1152,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1152,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1152,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1153,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1153,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1154,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1154,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1155,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1156,1,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1157,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1158,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1158,2,Immune-mediated hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1158,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1159,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1159,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1159,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1159,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1159,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1160,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1160,2,Autoimmune colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1160,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1160,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1160,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1160,6,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1160,7,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1160,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1160,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1161,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1161,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1161,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1161,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1161,5,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1161,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1161,7,Oxygen saturation abnormal,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1161,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1161,9,Vascular access complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1161,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1162,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1163,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1163,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1163,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1163,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1163,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1163,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1164,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1165,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1165,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1165,3,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1166,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1167,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1169,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1169,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1169,3,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1170,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1171,1,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1171,2,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
1172,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1173,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1174,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1174,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1174,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1174,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1174,5,Hypopituitarism,Anterior pituitary hypofunction,Hypothalamus and pituitary gland disorders,Endo,N
1174,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1174,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1174,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1175,1,Enterocolonic fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1175,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1175,3,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1175,4,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1176,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1176,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1177,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1177,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1177,3,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1178,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1179,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1179,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1179,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1179,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1180,2,Perforation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1180,3,Pneumoperitoneum,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1180,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1180,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1181,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1182,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1183,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1184,1,Cold dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1184,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1184,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1184,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1184,5,Immune-mediated neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1184,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1184,7,Oral toxicity,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1184,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1184,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1185,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1186,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1186,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1186,3,Immune-mediated pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1186,4,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1186,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1186,6,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1188,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1188,2,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1188,3,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1188,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1188,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1189,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1189,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1190,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1191,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1192,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1193,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1193,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1194,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1195,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1196,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1197,1,Cold dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1197,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1197,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1197,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1197,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1197,6,Oral toxicity,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1197,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1198,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1198,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1199,1,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
1200,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1201,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1202,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1203,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1204,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1204,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1204,3,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1204,4,Polymyalgia rheumatica,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1204,5,Troponin T increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1205,1,Cytokine abnormal,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1206,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1207,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1208,1,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1209,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1209,2,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1209,3,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1209,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1210,1,Blood bicarbonate decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1210,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1211,1,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1212,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1213,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1213,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1213,3,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1213,4,Bladder catheterisation,Therapeutic bladder catheterisation,Renal and urinary tract therapeutic procedures,Surg,N
1213,5,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1213,6,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1213,7,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,8,Blood chloride increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,9,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
1213,10,Blood fibrinogen increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1213,11,Blood luteinising hormone decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
1213,12,Blood magnesium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,13,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1213,14,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,15,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,16,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
1213,17,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1213,18,Carbon dioxide decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1213,19,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1213,20,Complement factor C3 decreased,Immune response protein analyses NEC,Immunology and allergy investigations,Inv,N
1213,21,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1213,22,Cortisol abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1213,23,Dermoid cyst,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
1213,24,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1213,25,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
1213,26,Glycosylated haemoglobin abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1213,27,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,28,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,29,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,30,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1213,31,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1213,32,High density lipoprotein decreased,Cholesterol analyses,Lipid analyses,Inv,N
1213,33,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1213,34,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1213,35,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1213,36,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1213,37,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1213,38,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1213,39,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,40,Monocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,41,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,42,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1213,43,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1213,44,Oxygen saturation increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1213,45,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1213,46,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1213,47,Protein total decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1213,48,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,49,Red blood cell count increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1213,50,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1213,51,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1213,52,Thyroxine decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1213,53,Tri-iodothyronine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
1213,54,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1214,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1214,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1215,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1216,1,Tumour pseudoprogression,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
1217,1,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
1218,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1219,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1220,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1221,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1222,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1222,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1222,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1223,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1224,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1224,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1225,1,Hospice care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,Y
1226,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1227,1,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
1227,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1228,1,Immune-mediated arthritis,Arthropathies NEC,Joint disorders,Musc,N
1229,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1229,2,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1229,3,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1229,4,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1230,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1230,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1230,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1230,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1230,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1230,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1231,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1231,2,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1231,3,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,Y
1231,4,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1231,5,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1232,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1233,1,Extraocular muscle disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1233,2,Immune-mediated enterocolitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1233,3,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1233,4,Immune-mediated myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
1233,5,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1233,6,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1234,1,Immune-mediated hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1234,2,Immune-mediated myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1234,3,Immune-mediated myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
1235,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1235,2,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1235,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1235,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1235,5,Headache,Headaches NEC,Headaches,Nerv,N
1235,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1235,7,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
1235,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1235,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1235,10,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1235,11,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1235,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1236,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1236,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1236,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1236,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1236,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1236,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1236,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1237,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1237,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
